A Trial to Describe the Safety and Immunogenicity of MenABCWY When Administered on 2 Schedules

NCT04440176 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

309

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningococcal Vaccine

Interventions

BIOLOGICAL: MenABCWY
BIOLOGICAL: Saline

Sponsor

Pfizer